MX2021000020A - Composicion y metodo para tratar el dolor. - Google Patents

Composicion y metodo para tratar el dolor.

Info

Publication number
MX2021000020A
MX2021000020A MX2021000020A MX2021000020A MX2021000020A MX 2021000020 A MX2021000020 A MX 2021000020A MX 2021000020 A MX2021000020 A MX 2021000020A MX 2021000020 A MX2021000020 A MX 2021000020A MX 2021000020 A MX2021000020 A MX 2021000020A
Authority
MX
Mexico
Prior art keywords
composition
treating pain
sup
pain
cannabidiol
Prior art date
Application number
MX2021000020A
Other languages
English (en)
Inventor
Harry Karelis
Original Assignee
Zelira Therapeutics Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zelira Therapeutics Operations Pty Ltd filed Critical Zelira Therapeutics Operations Pty Ltd
Publication of MX2021000020A publication Critical patent/MX2021000020A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La invención se relaciona con una composición farmacéutica que comprende ?9-tetrahidrocannabinol (THC) y cannabidiol (CBD) y una fracción de terpenos obtenida por extracción de una planta de Cannabis y su uso en el tratamiento del dolor.
MX2021000020A 2018-07-03 2019-07-03 Composicion y metodo para tratar el dolor. MX2021000020A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2018100924A AU2018100924A4 (en) 2018-07-03 2018-07-03 Composition and method for treating pain
PCT/AU2019/050700 WO2020006599A1 (en) 2018-07-03 2019-07-03 Composition and method for treating pain

Publications (1)

Publication Number Publication Date
MX2021000020A true MX2021000020A (es) 2021-05-27

Family

ID=63079646

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021000020A MX2021000020A (es) 2018-07-03 2019-07-03 Composicion y metodo para tratar el dolor.

Country Status (13)

Country Link
US (1) US20220218650A1 (es)
EP (1) EP3817733A4 (es)
KR (1) KR20210071939A (es)
AU (2) AU2018100924A4 (es)
BR (1) BR112020027080A2 (es)
CA (1) CA3104742A1 (es)
CL (1) CL2020003368A1 (es)
CO (1) CO2021001061A2 (es)
IL (1) IL279748A (es)
MX (1) MX2021000020A (es)
PE (1) PE20211650A1 (es)
SG (1) SG11202013239RA (es)
WO (1) WO2020006599A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3856172A4 (en) * 2018-09-28 2022-10-05 Visceral Therapeutics Inc. PHARMACEUTICALLY ACTIVE CANNABIS-BASED COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF GASTROINTESTINAL CONDITIONS
AU2020243439A1 (en) * 2019-03-21 2021-10-28 ZYUS Life Sciences US Ltd. Cannabinoid and application supported opioid tapering
WO2020223800A1 (en) * 2019-05-03 2020-11-12 Zyus Life Sciences Inc. Formulation for pain management
EP3972621A4 (en) * 2019-05-22 2023-01-25 Canopy Growth Corporation COMPOSITIONS COMPRISING CANNABINOIDS FOR THE MANAGEMENT OF PAIN
JP2023529476A (ja) * 2020-06-12 2023-07-10 ゼリラ セラピューティクス オペレーションズ ピーティーワイ リミテッド 慢性疼痛を治療するための組成物及び方法
US11478446B2 (en) 2020-08-28 2022-10-25 Teresa Ann HANLON Pain relieving formulations containing cannabis and methods of making same
KR102269823B1 (ko) * 2021-01-18 2021-06-28 주식회사 네이처센스 대마 추출물을 포함하는 대사성 질환의 예방 및 치료용 조성물
EP4362936A1 (en) * 2021-07-01 2024-05-08 Ananda Scientififc, Inc. Methods for treatment of pain with cannabinoids
WO2023126934A1 (en) * 2021-12-29 2023-07-06 Canonic Ltd. Cannabis compositions for treating pain and inflammation related disorders
WO2023144340A1 (en) 2022-01-28 2023-08-03 Vertanical GmbH Method for the production of a plant extract
WO2023144420A1 (en) 2022-01-31 2023-08-03 Vertanical GmbH Composition comprising delta-9-tetrahydrocannabinol and terpenes
WO2024044145A1 (en) * 2022-08-23 2024-02-29 Tribu Hemp Llc Cannabinoid and terpene composition to be applied on an absorbent material.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949582B1 (en) * 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
CA2895805A1 (en) * 2012-12-18 2014-06-26 Kotzker Consulting Llc Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
WO2016044370A1 (en) * 2014-09-16 2016-03-24 India Globalization Capital, Inc. Cannabinoid composition and method for treating pain
CN107205960A (zh) * 2014-10-21 2017-09-26 联合大麻公司 大麻提取物及其制备和使用方法
US20180000727A1 (en) * 2015-01-21 2018-01-04 Michael Willinsky Composition and methods to improve stability, dosing, pharmacodynamics and product shelf life of endocannabinoids, phytocannabinoids and synthetic cannabinoids delivered by nasal inhaer
CA2952335A1 (en) * 2015-12-19 2017-06-19 Delta 9 Gardening B.V. Therapeutic delivery formulations and systems comprising cannabinoids and terpenes
IL301006A (en) * 2016-03-16 2023-04-01 Buzzelet Development And Technologies Ltd Cannobinoid compounds are rich in terpenes
EP3630145A4 (en) * 2017-05-31 2021-04-07 Phytecs, Inc. PHARMACEUTICAL COMPOSITIONS OF CANNABIDIOL AND BETA-CARYOPHYLLENE AND METHOD FOR USING THEM
WO2019089558A1 (en) * 2017-10-30 2019-05-09 Endocanna Health, Inc. Graphical user interfaces for determining personalized endocannabinoid genotypes and associated recommendations

Also Published As

Publication number Publication date
KR20210071939A (ko) 2021-06-16
US20220218650A1 (en) 2022-07-14
AU2018100924A4 (en) 2018-08-09
AU2019297198A1 (en) 2021-01-28
CA3104742A1 (en) 2020-01-09
WO2020006599A1 (en) 2020-01-09
EP3817733A1 (en) 2021-05-12
SG11202013239RA (en) 2021-01-28
CL2020003368A1 (es) 2021-08-13
EP3817733A4 (en) 2022-05-04
BR112020027080A2 (pt) 2021-03-30
CO2021001061A2 (es) 2021-06-30
IL279748A (en) 2021-03-01
AU2019297198B2 (en) 2022-12-08
PE20211650A1 (es) 2021-08-24

Similar Documents

Publication Publication Date Title
MX2021000020A (es) Composicion y metodo para tratar el dolor.
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
MX2021000023A (es) Composicion y metodo para el ahorro de opioides.
MX2018007022A (es) Metodos para tratar la enfermedad de huntington.
MX2021003264A (es) Composiciones y metodos para tratar o prevenir enfermedades y/o trastornos causados por la exposicion a la contaminacion del aire.
PH12018502634A1 (en) Topical compositions of apremilast
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
AR106800A1 (es) Composiciones que comprenden cepas bacterianas
MX2017014195A (es) Hidrogenacion de aceite de cannabis.
SA521422031B1 (ar) مركبات 2 – فورميل – 3 – هيدروكسي فينيلوكسي ميثيل قادرة على تعديل الهيموجلوبين
MX2019015315A (es) Composiciones y tratamientos para el trastorno del sueño.
NZ729290A (en) Composition containing a mixture of plant extracts or a mixture of molecules contained in said plants, and use for controlling carbohydrate and/or lipid metabolism
MX2023002137A (es) Formulaciones que contienen aceite de semilla de granada, aceite del fruto de rosa canina y oleorresina o extracto de inula viscosa.
MX2021000024A (es) Composicion de cannabinoides y metodo para tratar el ptsd y/o la ansiedad.
MX2019009952A (es) Formulaciones de evolocumab de baja viscosidad y alta concentracion y metodos de elaboracion de las mismas.
CR20220656A (es) Unión de anticuerpos multiespecíficos a bcma
MX2023001296A (es) Composiciones y metodos para tratar enfermedades y trastornos.
MX2020006443A (es) Combinacion de un retinoide y un extracto de silybum marianum (l.) gaertn.
MX2018009662A (es) Metodo y composicion farmaceutica para tratamiento de neurodegeneracion.
MY193613A (en) Synergistic composition for osteoarthritis
MX2022015799A (es) Composicion y metodo para el tratamiento del dolor cronico.
MY160160A (en) Anti-wart pharmaceutical composition and method for treating wart
MX2019011489A (es) Alimento y cosmeticos saludables para aumentar la cantidad de celulas apoptoticas y para disminuir la cantidad de celulas necroticas y un metodo de fabricacion de un ingrediente derivado de semilla de uva con crecimiento forzado de brotes para aumentar la cantidad de celulas apoptoticas y para disminuir la cantidad de celulas necroticas.
MX2022007720A (es) Extractos enriquecidos con compuestos polifenolicos y metodos relacionados.
WO2018062876A3 (ko) 통증이 경감되는 골관절염 치료용 키트